VirTra Awarded Patents for TASER® Training and Simulating Firearms and Malfunctions
October 31 2019 - 8:00AM
VirTra, Inc. (NASDAQ: VTSI), a global
provider of training simulators for the law enforcement, military,
educational and commercial markets, today announced that the United
States Patent and Trademark Office has issued the company two new
patents: patent 10,438,503, which relates to VirTra’s TASER®
cartridge kits, and patent 10,436,539, which relates to mechanical
malfunction of real firearms used in simulation training.
Based on the parameters of patent 10,438,503, VirTra is the only
company in the United States that can produce or sell a specially
triggered training cartridge for the TASER line of products by
Axon, the global leader in connected public safety technologies.
The patent covers VirTra’s proprietary method of reliably
triggering the training device based on the unique acoustic sound
produced by a TASER Conducted Energy Weapon’s (CEW) electrical arc.
This innovation allows trainees to deploy the cartridges from a
real TASER CEW during simulation training and avoid high-voltage
feedback. It also allows trainees to practice with a TASER CEW’s
“ARC” and/or “Re-ARC” functions, which increases the realism of
each training session. By using a live CEW while training in
VirTra’s simulators, trainees are able to improve their technique
and develop proper habits that carry into real world situations.
The patent applies to both legacy units and the latest
multi-cartridge systems used for the TASER X2 and TASER 7
weapons.
“TASER CEWs have been classified as ‘less-lethal’ devices, and
as such, require the same type of high quality, judgmental
use-of-force simulation training as lethal devices like firearms,”
said Lon Bartel, Director of Training and Curriculum at VirTra. “By
combining live TASER CEW and VirTra training cartridges with
VirTra’s simulators and library of content, trainees have an
opportunity to develop critical decision-making skills when under
stress as well as further develop safe weapon handling by
practicing the removal and replacement of cartridges during
simulations that escalate.”
Based on the parameters of patent 10,436,539, VirTra is the only
company in the United States that can produce or sell a specially
designed kit that affordably converts a live firearm into a safe
and reliable training tool that can simulate mechanical malfunction
and therefore increase realism. This patent addresses the growing
need to safely, affordably, and accurately reproduce the
intricacies of real firearms for training purposes. Patent
10,436,539 expands VirTra’s growing library of intellectual
property related to affordably converting real firearms (whether
pistol or rifle) into suitable training tools that can be used in
realistic simulation training without the expense or hassle of
modifying the original firearm.
Bob Ferris, VirTra Chairman and CEO, added, “These new patents
are the latest progression in the strategy we outlined at the
beginning of the year to bolster our technological capabilities.
These patents not only expand our competitive moat by protecting
important simulated weapon technology, but they also help ensure
that VirTra remains an industry leader and continues to offer the
highest quality judgmental use-of-force simulation training
available.”
About VirTra VirTra (NASDAQ: VTSI) is a global
provider of judgmental use of force training simulators, firearms
training simulators and driving simulators for the law enforcement,
military, educational and commercial markets. The company’s
patented technologies, software, and scenarios provide intense
training for de-escalation, judgmental use-of-force, marksmanship
and related training that mimics real-world situations. VirTra’s
mission is to save and improve lives worldwide through practical
and highly-effective virtual reality and simulator technology.
Learn more about the company at www.VirTra.com.
About Axon
Axon (NASDAQ: AAXN) is a network of devices, apps and people
that helps public safety personnel become smarter and safer. With a
mission of protecting life, its technologies give customers the
confidence, focus and time they need to keep their communities
safe. Axon’s products impact every aspect of a public safety
officer's day-to-day experience. Axon works hard for those who put
themselves in harm's way for the rest of the community. To date,
there are more than 397,800 software seats booked on the Axon
network around the world and more than 223,000 lives and countless
dollars have been saved with the Axon network of devices, apps and
people. Learn more at www.axon.com or by calling (800) 978-2737.
Facebook is a trademark of Facebook, Inc., Twitter is a trademark
of Twitter, Inc., TASER 7, TASER X2, Axon and the Delta Logo are
trademarks of Axon Enterprise, Inc., some of which are registered
in the US and other countries. For more information, visit
www.axon.com/legal. All rights reserved.
Follow Axon here
- Axon on Twitter: https://twitter.com/axon_us
- Axon on Facebook:
https://www.facebook.com/Axon.ProtectLife/
Forward-Looking Statements: This news release
includes certain information that may constitute forward-looking
statements made pursuant to the safe harbor provision of the
Private Securities Litigation Reform Act of 1995. Forward-looking
statements are typically identified by terminology such as “could,”
“may,” “will,” “expects,” “anticipates,” “future,” “intends,”
“plans,” “believes,” “estimates,” “proposed,” “planned,”
“potential” and similar expressions, or are those, which, by their
nature, refer to future events. All statements, other than
statements of historical fact, included herein, including
statements about VirTra’s beliefs and expectations, are
forward-looking statements. Forward-looking information is
necessarily based upon a number of assumptions that, while
considered reasonable, are subject to known and unknown risks,
uncertainties and other factors which may cause the actual results
and future events to differ materially from those expressed or
implied by such forward-looking information. Although VirTra
believes that such statements are reasonable, it can give no
assurance that such forward-looking information will prove to be
accurate. VirTra cautions investors that any forward-looking
statements by the Company are not guarantees of future results or
performance, and that actual results may differ materially from
those in forward-looking statements as a result of various factors.
Accordingly, due to the risks, uncertainties and assumptions
inherent in forward-looking information, readers and prospective
investors in the Company’s securities should not place undue
reliance on forward-looking information. All forward-looking
information contained in this press release is given as of the date
hereof, is based upon the opinions and estimates of management and
information available to management as at the date hereof and is
subject to change. The Company assumes no obligation to revise or
update forward-looking information to reflect new circumstances,
whether as a result of new information, future events or otherwise,
except as required by law.
Investor Relations Contact: Matt Glover or
Charlie Schumacher VTSI@gatewayir.com 949-574-3860
Axon Enterprise (NASDAQ:AAXN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Axon Enterprise (NASDAQ:AAXN)
Historical Stock Chart
From Sep 2023 to Sep 2024